Concept in patent law
Novelty is one of the patentability requirement for a patent claim, whose purpose is to prevent issuing patents on known things, i.e. to prevent public knowledge from being taken away from the public domain.[1]
An invention is anticipated (i.e. not new) and therefore not patentable if it was known to the public before the priority date of the patent application. Although the concept of "novelty" in patent law appears simple and self-explanatory, this view is very far from reality.[attribution needed] Some of the most contentious questions of novelty comprise:[original research?]
- inventor's own prior disclosures (only a few countries provide a grace period, most notably, 1 year in the US);[2]
- new uses of known things, such as pharmaceuticals;
- a broader question of (2) is inherent anticipation;[3]
- patenting things, which are newly discovered in (or isolated from) nature (see Association for Molecular Pathology v. Myriad Genetics, Inc.)[4] This question overlaps with patentable subject matter.
- ^ Legal Research Service for the Boards of Appeal, European Patent Office, Case Law of the Boards of Appeal of the EPO (9th edition, July 2019), i.c.1 : "I. Patentability; C. Novelty; 1. General" ("An invention can be patented only if it is new. An invention is considered to be new if it does not form part of the state of the art. The purpose of Art. 54(1) EPC is to prevent the state of the art being patented again (T 12/81, OJ 1982, 296; T 198/84, OJ 1985, 209).")
- ^ World Intellectual Property Organization (June 2023). "Certain aspects of national/regional patent laws" (PDF). Retrieved 14 November 2023.
- ^ Patenting New Uses for Old Inventions. 2020. Vanderbilt Law Rev. 73/2, 479-534. S.B. Seymore.
- ^ Myriad and its implications for patent protection of isolated natural products in the United States. 2014. Chin Med. 9/17. A.Y. Wong, A.W. Chan. doi: 10.1186/1749-8546-9-17.